Latest Articles

Publication Date
TiumBio to present positive merigolix phase 2 results at ESHRE 2025 - koreabiomed.com

TiumBio to present positive merigolix phase 2 results at ESHRE 2025 koreabiomed.com

Published: June 26, 2025, 1:33 a.m.
AZ redefines endometrial and ovarian cancer playbook - koreabiomed.com

AZ redefines endometrial and ovarian cancer playbook koreabiomed.com

Published: June 25, 2025, 12:05 a.m.
SNUBH study finds lymph node dissection unnecessary in some endometrial cancer cases - koreabiomed.com

SNUBH study finds lymph node dissection unnecessary in some endometrial cancer cases koreabiomed.com

Published: June 5, 2025, 3:23 a.m.
MSD launches phase 3 Keytruda combo trial in tough-to-treat endometrial cancer in Korea - koreabiomed.com

MSD launches phase 3 Keytruda combo trial in tough-to-treat endometrial cancer in Korea koreabiomed.com

Published: May 30, 2025, 1:52 a.m.
Daewon Pharm’s uterine fibroid drug meets primary endpoint in P2 trial - koreabiomed.com

Daewon Pharm’s uterine fibroid drug meets primary endpoint in P2 trial koreabiomed.com

Published: May 7, 2025, 6:51 a.m.
Association Between Levonorgestrel-Releasing Intrauterine System Exposure Duration and Breast Cancer Incidence.

To investigate the association between the duration of levonorgestrel-releasing intrauterine system (LNG-IUS) use and breast cancer risk in Korean women.

Published: March 13, 2025, midnight
South Korean singer Wheesung found dead at home - CNA

South Korean singer Wheesung found dead at home CNA

Published: March 11, 2025, 1:02 a.m.
Broad-Spectrum Adverse Events of Special Interests Based on Immune Response Following COVID-19 Vaccination: A Large-Scale Population-Based Cohort Study.

Background/Objectives: Current studies on adverse events related to the COVID-19 vaccine have predominantly focused on severe, life-threatening side effects. However, numerous less severe but common adverse events (AEs) remain underreported …

Published: March 6, 2025, midnight
Can immuno-oncology revolutionize endometrial cancer treatment in Korea? - KBR

Can immuno-oncology revolutionize endometrial cancer treatment in Korea? KBR

Published: March 4, 2025, 7:13 a.m.
S. Korea says DeepSeek removed from local app stores pending privacy review - Courier Mail

S. Korea says DeepSeek removed from local app stores pending privacy review Courier Mail

Published: Feb. 17, 2025, 3:44 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!